The Canadian journal of cardiology · 2026
Incidence and Predictors of Pacemaker Implantation Post-Transcatheter Aortic Valve Replacement in Patients with Pre-existing Right Bundle-Branch Block.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Prabhu Rahul, Rao Karan, Ciofani Jonathan L, Litkouhi Princess Neila, Baer Alexandra, Hansen Peter, Bhindi Ravinay
Аннотация
BACKGROUND: Pre-existing right bundle branch block (RBBB) is the leading predictor of permanent pacemaker implantation (PPI) following transcatheter aortic valve implantation (TAVI). The applicability of conventional PPI predictors in this high-risk subgroup remains unclear. This review evaluates PPI incidence and associated predictors in TAVI patients with pre-existing RBBB.
METHODS: A systematic review of PubMed, Scopus, Embase, and Web of Science identified studies reporting PPI incidence and predictors in RBBB patients undergoing TAVI. Studies not addressing RBBB-specific factors were excluded. Pooled PPI incidence was calculated, and a qualitative narrative synthesis of predictors was performed.
RESULTS: Of 2269 identified references, 22 studies with 429,342 patients met the inclusion criteria. Within the RBBB cohort, the mean age was 81.6 ± 7.4 years, with 64.2% being male, and 23.7% having atrial fibrillation. Balloon-expandable valves were used in 69.8% of cases, and the transfemoral approach in 88.6%. The pooled PPI incidence was 37% across 17 studies. Substantial interstudy heterogeneity necessitated further analysis among 13 studies reporting consistent 30-day follow-up, which yielded 39% incidence. PPI predictors in the RBBB cohort encompassed demographic, anatomic, electrophysiological, and procedural domains.
CONCLUSIONS: Patients with baseline RBBB have significantly higher post-TAVI PPI rates. Identifying RBBB specific predictors could facilitate individualized procedural planning and risk stratification. This review reinforces how both traditional (eg, implantation depth) and nontraditional (eg, female sex, myocardial fibrosis, calcium volume, and distribution) factors have an amplified role in predicting PPI risk, emphasizing the need for further research in this subgroup to improve risk stratification and reduce PPI incidence.
REGISTRATION: PROSPERO CRD420251057657.
METHODS: A systematic review of PubMed, Scopus, Embase, and Web of Science identified studies reporting PPI incidence and predictors in RBBB patients undergoing TAVI. Studies not addressing RBBB-specific factors were excluded. Pooled PPI incidence was calculated, and a qualitative narrative synthesis of predictors was performed.
RESULTS: Of 2269 identified references, 22 studies with 429,342 patients met the inclusion criteria. Within the RBBB cohort, the mean age was 81.6 ± 7.4 years, with 64.2% being male, and 23.7% having atrial fibrillation. Balloon-expandable valves were used in 69.8% of cases, and the transfemoral approach in 88.6%. The pooled PPI incidence was 37% across 17 studies. Substantial interstudy heterogeneity necessitated further analysis among 13 studies reporting consistent 30-day follow-up, which yielded 39% incidence. PPI predictors in the RBBB cohort encompassed demographic, anatomic, electrophysiological, and procedural domains.
CONCLUSIONS: Patients with baseline RBBB have significantly higher post-TAVI PPI rates. Identifying RBBB specific predictors could facilitate individualized procedural planning and risk stratification. This review reinforces how both traditional (eg, implantation depth) and nontraditional (eg, female sex, myocardial fibrosis, calcium volume, and distribution) factors have an amplified role in predicting PPI risk, emphasizing the need for further research in this subgroup to improve risk stratification and reduce PPI incidence.
REGISTRATION: PROSPERO CRD420251057657.